130. Psychedelics and Women's Health with Dr Grace Blest-Hopley

·1 hr 2 min·5 clips

Two MDMA studies show drastically different anxiety outcomes in women depending on whether their menstrual cycle phase was tracked.

Dr. Grace discusses the understudied intersection of psychedelics and women's health, focusing on how menstrual cycles, estrogen levels, and menopause impact psychedelic effects and clinical trial design. She highlights the need for female-specific protocols, shares insights from her research at Hystelica, and explores potential therapeutic applications for conditions like PMDD and traumatic brain injury.

As heard by us

A careful look at how menstrual timing and related symptoms may shape psychedelic experience.

The episode zeroes in on a gap drug talk often skips: how psychedelics may land differently in women's bodies, with menstrual timing, PMS, and PMDD-like symptoms in the frame.

Read the full review in PlayNext →

Why you'd press play

Before a retreat, hear why this episode says women should be asked better questions about psychedelic timing.

Read the full recommendation in PlayNext →

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from The Drug Science Podcast